HSP90 and the chaperoning of cancer

被引：2007

作者：

Whitesell, L ^{[1
]}

Lindquist, SL

机构：

[1] Univ Arizona, Steele Mem Childrens Res Ctr, Tucson, AZ 85724 USA

[2] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA

来源：

NATURE REVIEWS CANCER | 2005年 / 5卷 / 10期

关键词：

D O I：

10.1038/nrc1716

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Standing watch over the proteome, molecular chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival. This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution. Pharmacologically 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.

引用

页码：761 / 772

页数：12

共 147 条

[91]

Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420

[92] Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones [J].

Prodromou, C ;

Siligardi, G ;

O'Brien, R ;

Woolfson, DN ;

Regan, L ;

Panaretou, B ;

Ladbury, JE ;

Piper, PW ;

Pearl, LH .

EMBO JOURNAL, 1999, 18 (03) :754-762

[93] Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone [J].

Prodromou, C ;

Roe, SM ;

OBrien, R ;

Ladbury, JE ;

Piper, PW ;

Pearl, LH .

CELL, 1997, 90 (01) :65-75

[94] Structure and Functional Relationships of Hsp90 [J].

Prodromou, Chrisostomos ;

Pearl, Laurence H. .

CURRENT CANCER DRUG TARGETS, 2003, 3 (05) :301-323

[95] Hsp90 as a capacitor of phenotypic variation [J].

Queitsch, C ;

Sangster, TA ;

Lindquist, S .

NATURE, 2002, 417 (6889) :618-624

[96]

Rahmani M, 2003, CANCER RES, V63, P8420

[97] Proteasome inhibition as a novel therapeutic target in human cancer [J].

Rajkumar, SV ;

Richardson, PG ;

Hideshima, T ;

Anderson, KC .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) :630-639

[98]

Ralhan R, 1995, CLIN CANCER RES, V1, P1217

[99] The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50cdc37 [J].

Roe, SM ;

Ali, MMU ;

Meyer, P ;

Vaughan, CK ;

Panaretou, B ;

Piper, PW ;

Prodromou, C ;

Pearl, LH .

CELL, 2004, 116 (01) :87-98

[100] Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin [J].

Roe, SM ;

Prodromou, C ;

O'Brien, R ;

Ladbury, JE ;

Piper, PW ;

Pearl, LH .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) :260-266

← 5 6 7 8 9 10 11 12 13 14 →